№ lp_1_06041
File format: docx
Character count: 6929
File size: 21 KB
Year:
2018
Region / City:
Queensland
Topic:
Legal Procedure
Document Type:
Court Order
Organization / Institution:
Supreme Court of Queensland
Author:
N/A
Target Audience:
Legal professionals
Effective Period:
Until further order of the Court
Approval Date:
2018
Amendment Date:
N/A
Context:
A document outlining the terms and procedures for document management and disclosure in legal proceedings, as agreed by the parties in a case before the Supreme Court of Queensland.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / city:
England
Topic:
Immunization
Document type:
Patient Group Direction (PGD)
Organization / institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Professor Shamez Ladhani, David Green
Target audience:
Healthcare professionals involved in immunization
Period of validity:
From 5 January 2026 to 5 January 2029
Approval date:
5 January 2026
Amendment date:
2 June 2025, 16 December 2025
Description:
A document detailing the administration guidelines for the pneumococcal polysaccharide conjugate vaccine (PCV13, PCV15) for children under 2 years old in the UK.
Year:
2025
Region / City:
[insert local health board name]
Topic:
Community Pharmacy, Common Ailments Service, Docusate Sodium
Document Type:
Patient Group Direction (PGD)
Organization / Institution:
Welsh Medicines Advice Service
Author:
Dianne Burnett
Target Audience:
Pharmacists working within the Common Ailments Service of the Clinical Community Pharmacy Service
Period of Validity:
01 November 2025 - 31 October 2028
Approval Date:
29 August 2025
Review Date:
31 July 2028
Expiration Date:
31 October 2028
Year:
2025
Region / city:
[insert local health board name]
Theme:
Vaccination
Document type:
Patient Group Direction (PGD)
Authorising organisation:
NHS Wales
Target audience:
Healthcare professionals (Registered)
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
07 August 2025
Amendment date:
30 June 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Year:
2025
Region / city:
England
Topic:
Influenza immunisation
Document type:
Patient Group Direction (PGD)
Organisation:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Jamie Lopez-Bernal, Greta Hayward
Target audience:
Healthcare practitioners, NHS organisations
Period of validity:
From 1 September 2025 to 1 April 2026
Approval date:
3 July 2025
Revision history:
Updated annually, latest update 9 July 2025
Reference no:
HPV (GBMSM) PGD
Version no:
v5.0
Valid from:
1 September 2025
Review date:
1 April 2028
Expiry date:
1 September 2028
Author:
Suki Hunjunt, Sharif Ismail, David Green
Region / city:
England
Target audience:
Healthcare practitioners administering HPV vaccine to GBMSM
Type of document:
Patient Group Direction
Organisation:
UK Health Security Agency (UKHSA)
Date of approval:
17 July 2025
Date of modifications:
16 July 2025
Context:
A formal Patient Group Direction for the administration of HPV vaccine to GBMSM, detailing legal, clinical, and procedural requirements for healthcare practitioners in England.
Reference no:
Hib/MenC PGD
Version no:
v6.0
Valid from:
1 July 2025
Expiry date:
30 April 2026
Authorising organisations:
UK Health Security Agency (UKHSA)
Target audience:
Registered healthcare practitioners
Responsible body:
UKHSA
Note:
Amendment history
v1.0 and v2.0:
See previous versions of this PGD template for details (19 January 2016 to 23 April 2018)
v3.0:
PHE Hib/MenC PGD amended to: include vaccination of individuals for the prevention of secondary cases of meningococcal group C disease (24 April 2018)
v4.0:
PHE Hib/MenC PGD amended to: remove reference to individuals with an underlying medical condition (5 March 2020)
v5.0:
UKHSA Hib/MenC PGD amended to: include minor rewording of standard text, layout and formatting changes (4 May 2022)
v6.0:
UKHSA Hib/MenC PGD amended to: include minor rewording, updated references, and changes to the childhood immunisation schedule (2 June 2025)
Developed by:
Christina Wilson (Lead Pharmacist), Professor Shamez Ladhani (Paediatric Infectious Diseases Consultant), David Green (Nurse Consultant for Immunisation Programmes)
Peer-reviewed by:
UKHSA Immunisations PGD Expert Panel
Date approved:
2 June 2025
Year:
2025
Region / city:
Victoria, Australia
Subject:
Development contributions, planning and infrastructure
Document type:
Ministerial direction, reporting requirements
Agency / institution:
Minister for Planning
Author:
Minister for Planning
Target audience:
Planning authorities, development agencies, collecting agencies
Period of validity:
Ongoing
Approval date:
11 April 2025
Amendment date:
N/A
Year:
2025
Region:
England
Subject:
Hepatitis B vaccination for renal patients
Document Type:
Patient Group Direction (PGD)
Authorising Organisation:
UK Health Security Agency (UKHSA)
Target Audience:
Registered healthcare professionals
Period of Validity:
28 February 2025 - 28 February 2028
Approval Date:
28 February 2025
Amendment Date:
21 February 2025
Year:
2024
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction
Organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr. Mary Ramsay, David Green
Target audience:
Registered healthcare practitioners
Period of validity:
10 October 2024 - 30 April 2027
Approval date:
4 October 2024
Amendments date:
9 October 2024
Year:
20xx
Region / city:
Ontario
Theme:
Legal Proceedings
Document Type:
Practice Direction
Organization / Institution:
Ontario Court of Justice
Author:
Ontario Court of Justice
Target Audience:
Legal professionals, Accused individuals
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2022
Region / City:
England and Wales, Birmingham, Bristol, Cardiff, Leeds, Liverpool, Manchester, Newcastle
Topic:
Legal Practice Direction, Disclosure
Document Type:
Practice Direction
Authority / Institution:
Business and Property Courts
Author:
Unknown
Target Audience:
Legal professionals, Court personnel
Period of validity:
From 1 October 2022
Approval Date:
1 October 2022
Date of last modification:
Not specified
Note:
Year
Organization / Institution:
NHS Scotland
Author:
Dr Laura Ryan, Dr John McAnaw, Mr Jim Miller
Target Audience:
Qualified health professionals within NHS Scotland
Changes History:
Eligibility age extended, new conditions added, clarifications made
Clinical Situation:
Acute uncomplicated urinary tract infection (UTI) in non-pregnant females aged 16 years and over.
Year:
2024
Region / City:
Scotland
Topic:
Pharmaceutical Guidelines
Document Type:
Patient Group Direction (PGD)
Organization / Institution:
NHS Scotland
Author:
Dr. Ronald Cook, Dr. John McAnaw
Target Audience:
Community Pharmacists
Effective Date:
20th February 2024
Expiry Date:
19th February 2027
Year:
2026
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr Vanessa Saliba, David Green
Target audience:
Healthcare practitioners
Validity period:
20 January 2026 – 30 November 2028
Approval date:
20 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Note:
Change history
Year:
2019
Region / City:
Uganda
Theme:
National Development, Government Policies
Document Type:
Thematic Report
Organization / Institution:
National Planning Authority
Author:
National Planning Authority
Target Audience:
Government officials, policy analysts, development planners
Period of Validity:
2015/16-2019/20
Approval Date:
March 2019
Date of Changes:
Not specified
Year:
2023
Region / City:
Wisconsin
Theme:
Construction, HMA Pavement, Testing Procedures
Document Type:
Test Method
Organization / Institution:
Wisconsin Department of Transportation (WisDOT)
Author:
Wisconsin Department of Transportation (WisDOT)
Target Audience:
Contractors, Engineers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual Description:
Detailed test methods and sampling procedures for HMA PWL QMP projects to ensure quality control during the paving process.
Year:
Not specified
Region / City:
Not specified
Subject:
BioChemUDM, Labels, Relationships
Document Type:
Appendix
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Not specified
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Document type:
Technical approval schedule
Appendix:
Appendix A
Subject area:
Structural design standards
Infrastructure type:
Highway bridges and structures
Standards framework:
Eurocodes and UK National Annexes
Jurisdiction:
United Kingdom
Responsible role:
Designer
Referenced standards bodies:
British Standards Institution, CEN
Applicable disciplines:
Structural engineering
Scope of documents:
Basis of design, actions on structures, concrete structures, steel structures
Revision status:
Revisions current as of 23 July 2024
Validity period:
Various standards valid until 30 March 2028
Superseding standards:
Referenced where applicable
Associated guidance:
CD 350
Year:
1991-2014
Region / City:
UK
Topic:
Labour Market Transitions, Demographic Analysis
Document Type:
Research Supplement
Author:
Not specified
Target Audience:
Researchers, Policy Analysts, Demographers
Period of Validity:
1991-2014
Approval Date:
Not specified
Date of Amendments:
Not specified